C4 Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $11M | 2.0M | 5.65 |
| 2023-09-30 | $3.6M | 1.9M | 1.86 |
| 2023-06-30 | $5.2M | 1.9M | 2.75 |
| 2023-03-31 | $6.6M | 2.1M | 3.14 |
| 2022-12-31 | $12M | 2.1M | 5.90 |
| 2022-06-30 | $15M | 2.0M | 7.54 |
| 2022-03-31 | $49M | 2.0M | 24.26 |
| 2021-09-30 | $87M | 1.9M | 44.68 |
| 2021-06-30 | $53M | 1.4M | 37.83 |
| 2021-03-31 | $14M | 388k | 37.01 |
| 2020-12-31 | $15M | 452k | 33.13 |